Close Menu

court of appeals

The court upheld a judgement of no interference-in-fact from the Patent Trial and Appeal Board, leaving the Broad in control of key CRISPR IP.

The plaintiffs say the USPTO made several errors when it determined the Broad Institute had the right to patent the use of CRISPR/Cas9 in eukaryotes.

The so-called '540 patent has been the focal point of a series of lawsuits between Sequenom and other NIPT firms since 2011. 

NEW YORK (GenomeWeb News) – A federal appeals court today has for a second time reversed a lower district court's decision that isolated genes are not patentable, but it also partly affirmed the District Court's decision that certain methods patents "comparing" or "analyzing" gene sequences may n

The US Court of Appeals reversed the earlier decision in the case challenging Myriad's BRCA patents, saying that isolated DNA is patent eligible under US law.

Myriad Genetics and the University of Utah Research Foundation are appealing a decision rendered in March that found that the company's BRCA gene patents are "unpatentable."

A US Appeals Court overturned a lower court's decision in favor of Life Technologies predecessor firm Applera, clearing the way for it to pursue a claim for "substantial damages."

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.